Wellington Management Group’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
Other funds holding FULC
Wellington Management Group's FULC Position: Q3 2026 in Review
Wellington Management Group sold out of Fulcrum Therapeutics (FULC) in Q3 2026, closing a stake of 285,084 shares — an estimated $1.04M sold.
Wellington Management Group first reported a position in FULC in Q1 2024 and held it in 9 quarters. The position peaked at $1.66M in Q4 2025. 151 funds tracked by Wall St. Rank hold FULC as of Q3 2026.
- Wellington Management Group reported no remaining Fulcrum Therapeutics position as of Q3 2026 after selling out during the quarter.
- Wellington Management Group sold 285,084 Fulcrum Therapeutics shares in Q3 2026, an estimated $1.04M.
- Wellington Management Group first reported a position in Fulcrum Therapeutics in Q1 2024 and held it in 9 quarters.
- Wellington Management Group's Fulcrum Therapeutics position peaked at $1.66M in Q4 2025.
- 151 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q3 2026.
Based on Wellington Management Group's 13F filing for Q3 2026, filed 16 Nov 2026.